Supporting the next generation of researchers

American Cancer Society awards pilot funding for early-stage investigators

The American Cancer Society has awarded the University of Cincinnati Cancer Center an Institutional Research Grant. 

Cancer Center member David Plas, PhD, is primary investigator for the grant, with members Maria Czyzyk-Krzeska, MD, PhD, and Kathryn Wikenheiser-Brokamp, MD, PhD, serving as co-principal investigators.

The American Cancer Society awards Institutional Research Grants to academic and nonprofit organizations that have a track record of outstanding cancer research and a pool of experienced researchers who can mentor junior faculty. The purpose is to support early-stage faculty investigators in initiating cancer research projects so they can obtain preliminary results that will enable them to compete successfully for national research grants.


David Plas, PhD. Photo/University of Cincinnati.

The grant will provide a total of $360,000 in pilot funding over three years.

“I am excited for the benefits that this grant will bring to our early-stage investigators, the added recognition it will bring to the Cancer Center and for the opportunity to further partner with the ACS," said Plas, professor and Anna and Harold W. Huffman endowed chair in glioblastoma experimental therapeutics in the Department of Cancer Biology in UC’s College of Medicine.

"The American Cancer Society is committed to investing in the careers of the best and the brightest early-stage investigators who can bring innovative ideas to the forefront,” said Natasha Coleman, American Cancer Society vice president of community impact. “We are confident that this institutional research grant to the University of Cincinnati Cancer Center, with leadership and expertise from co-investigators Dr. David Plas, Dr. Maria Czyzyk-Krzeska and Dr. Kathryn Wikenheiser-Brokamp, will provide essential mentoring to launch new researchers who are able to further our understanding of cancer and its treatment.” 

"Receiving this award from the American Cancer Society is a validation of the cancer research happening across campus and our commitment to developing junior faculty. This award puts us in good company with peer institutions, including Case Comprehensive Cancer Center at Case Western Reserve University and Markey Cancer Center at the University of Kentucky. We are incredibly proud of the work the grant co-PIs put into receiving this award, and we are excited for the impact this will have on our early-stage investigators," said Syed Ahmad, MD, and William Barrett, MD, co-directors at the University of Cincinnati Cancer Center.

Over the next three years, up to nine early-stage Cancer Center investigators will benefit from this new pilot program. With matching funds provided by the Cancer Center, each funded investigator can receive up to $80,000 in support. Information on eligibility and how to apply will be available later this year.

Headshot of Brad McElhaney

Brad McElhaney

Director of Membership Communications & Marketing, University of Cincinnati Cancer Center

Impact Lives Here

The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.

Featured photo at top: Research assistant Grace Goodhart, right, works in the laboratory as Andrew Waters, PhD, left, looks on. Photo/Andrew Higley/UC Marketing + Brand.

Related Stories


Improving treatment for deadly brain tumors

May 5, 2023

The University of Cincinnati's Soma Sengupta was a co-first author on research published in Cell Reports Medicine New that found that a cancer stem cell test can accurately decide more effective treatments and lead to increased survival for patients with glioblastoma, a deadly brain tumor.


Learning more about how cancer affects stroke risk

October 16, 2023

A collaborative team led by University of Cincinnati, University of North Carolina and Duke University researchers is studying how specific cancers and treatments affect patients' risk of stroke.